Liquidia Corporation Common Stock vs TD SYNNEX Corporation Common Stock — how do they compare? Liquidia Corporation Common Stock trades at $33.69 (market cap $2.40B), while TD SYNNEX Corporation Common Stock trades at $262 (market cap $22.02B). The key difference: TD SYNNEX Corporation Common Stock is far larger — about 9.2× Liquidia Corporation Common Stock's market cap, and TD SYNNEX Corporation Common Stock pays a 0.7% dividend while Liquidia Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Liquidia Corporation Common Stock for 0 Days and TD SYNNEX Corporation Common Stock for 0 Days on average.
| LQDA | SNX | |
|---|---|---|
Market Cap | $2.40B | $22.02B |
Volume | 2,857,547 | 614,208 |
Sector | Health | Technology |
52-Week High | $91.03 | $290.14 |
52-Week Low | $22.02 | $142.42 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $2.30B | $26.79B |
Dividend Yield | — | 0.7% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →TD SYNNEX Corporation is a global IT distributor and solutions aggregator that distributes endpoint devices and data-center technologies from technology vendors to resellers and customers worldwide.
Read more on SNX →